A detailed history of Jump Financial, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Jump Financial, LLC holds 24,991 shares of RARE stock, worth $1.07 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
24,991
Previous 27,289 8.42%
Holding current value
$1.07 Million
Previous $1.12 Million 23.82%
% of portfolio
0.03%
Previous 0.02%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$40.21 - $59.36 $92,402 - $136,409
-2,298 Reduced 8.42%
24,991 $1.39 Million
Q2 2024

Aug 14, 2024

BUY
$37.42 - $51.61 $1.02 Million - $1.41 Million
27,289 New
27,289 $1.12 Million
Q3 2023

Oct 21, 2024

BUY
$34.92 - $46.66 $219,821 - $293,724
6,295 Added 36.72%
23,436 $835,000
Q3 2023

Nov 07, 2023

BUY
$34.92 - $46.66 $219,821 - $293,724
6,295 Added 36.72%
23,436 $835,000
Q2 2023

Oct 21, 2024

BUY
$37.35 - $52.15 $104,692 - $146,176
2,803 Added 19.55%
17,141 $790,000
Q2 2023

Aug 07, 2023

BUY
$37.35 - $52.15 $104,692 - $146,176
2,803 Added 19.55%
17,141 $790,000
Q1 2023

Oct 21, 2024

SELL
$36.99 - $48.71 $479,057 - $630,843
-12,951 Reduced 47.46%
14,338 $574,000
Q1 2023

May 03, 2023

SELL
$36.99 - $48.71 $1.52 Million - $2 Million
-40,968 Reduced 74.08%
14,338 $574,000
Q4 2022

Feb 13, 2023

BUY
$33.72 - $46.33 $1.47 Million - $2.02 Million
43,508 Added 368.77%
55,306 $2.56 Million
Q3 2022

Nov 07, 2022

BUY
$39.96 - $66.14 $471,448 - $780,319
11,798 New
11,798 $489,000

Others Institutions Holding RARE

About Ultragenyx Pharmaceutical Inc.


  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.01B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.